Podcasts

CogCast is the Cogstate podcast series on measuring cognition in clinical trials.

Cognitive impairment and decline in cognitively normal older adults with high amyloid-b: A meta-analysis

June 1, 2017

The scientific community widely agrees that in cognitively normal older adults, abnormal levels of amyloid-beta, seen through PET imaging or CSF sampling, indicates that the pathophysiological process of Alzheimer’s disease has, in fact, begun; although it […]

Measuring Cognition in Oncology Trials

December 22, 2015

The third entry in Cogstate’s podcast series on measuring cognition in clinical trials focuses on cognitive measures specifically in oncology trials. Dr. Brian Harel, Clinical Science Director at Cogstate and Assistant Clinical Professor at the Yale […]

Cognitive Measures in Pediatric Drug Development: Key Considerations, Tools and Technologies

November 16, 2015

The second podcast in our series – ‘Cognitive Measures in Pediatric Drug Development: Key Considerations, Tools and Technologies’ – sees Dr. Brian Harel, Clinical Science Director at Cogstate discussing the requirements of pharmaceutical companies by regulators […]

Early Phase Decision Making About Cognitive Safety

September 22, 2015

The first entry in Cogstate’s podcast series – ‘Measuring Cognition in Clinical Trials’ – sees Professor Paul Maruff, Chief Scientific Officer at Cogstate, discussing methodology for measuring cognition in early phase research, as well as delving […]

How can we help you optimize the measurement of brain health?

Please fill out the form to get in touch